Tilmann Kallinich

7.3k total citations
116 papers, 2.6k citations indexed

About

Tilmann Kallinich is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Tilmann Kallinich has authored 116 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 51 papers in Immunology and 48 papers in Hematology. Recurrent topics in Tilmann Kallinich's work include Inflammasome and immune disorders (52 papers), Autoimmune and Inflammatory Disorders Research (47 papers) and Adolescent and Pediatric Healthcare (19 papers). Tilmann Kallinich is often cited by papers focused on Inflammasome and immune disorders (52 papers), Autoimmune and Inflammatory Disorders Research (47 papers) and Adolescent and Pediatric Healthcare (19 papers). Tilmann Kallinich collaborates with scholars based in Germany, United States and Switzerland. Tilmann Kallinich's co-authors include Eckard Hamelmann, Seza Özen, Richard A. Kroczek, Max Löhning, Marco Gattorno, Helmut Wittkowski, Huri Özdoğan, Dirk Foell, R. Keitzer and Erkan Demirkaya and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Tilmann Kallinich

97 papers receiving 2.6k citations

Peers

Tilmann Kallinich
Sinisa Savic United Kingdom
Norbert Blank Germany
Kieron Leslie United States
Joung‐Liang Lan Taiwan
Alexandre Bélot France
Francesco Caso Italy
Michael Frosch Germany
Serena Colafrancesco Italy
Akrivi Chrysanthopoulou Greece
Toru Mima Japan
Sinisa Savic United Kingdom
Tilmann Kallinich
Citations per year, relative to Tilmann Kallinich Tilmann Kallinich (= 1×) peers Sinisa Savic

Countries citing papers authored by Tilmann Kallinich

Since Specialization
Citations

This map shows the geographic impact of Tilmann Kallinich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilmann Kallinich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilmann Kallinich more than expected).

Fields of papers citing papers by Tilmann Kallinich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilmann Kallinich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilmann Kallinich. The network helps show where Tilmann Kallinich may publish in the future.

Co-authorship network of co-authors of Tilmann Kallinich

This figure shows the co-authorship network connecting the top 25 collaborators of Tilmann Kallinich. A scholar is included among the top collaborators of Tilmann Kallinich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilmann Kallinich. Tilmann Kallinich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Klein, Ariane, et al.. (2024). LBA0008 EFFECTIVENESS OF CANAKINUMAB FOR FIRST LINE STEROID FREE TREATMENT IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS. Annals of the Rheumatic Diseases. 83. 238–239. 1 indexed citations
3.
Klotsche, Jens, Ina Liedmann, Martina Niewerth, et al.. (2024). Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort. Pediatric Rheumatology. 22(1). 93–93.
4.
Oommen, Prasad T., et al.. (2024). Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry. Rheumatology and Therapy. 12(1). 137–155.
5.
Kuemmerle‐Deschner, Jasmin, Tilmann Kallinich, Jörg Henes, et al.. (2024). Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry. RMD Open. 10(1). e003890–e003890. 9 indexed citations
6.
Maier, R., Carl Christoph Goetzke, Ute Hoffmann, et al.. (2024). Age-stratification reveals age-specific intestinal microbiota signatures in juvenile idiopathic arthritis. SHILAP Revista de lepidopterología. 11(1). 12–12. 2 indexed citations
7.
Gattorno, Marco, Laura Obici, Inmaculada Calvo Penadés, et al.. (2023). Long‐Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor–Associated Periodic Syndrome: Results From a Phase III Trial. Arthritis & Rheumatology. 76(2). 304–312. 4 indexed citations
8.
Minden, Kirsten, et al.. (2023). Monogene Varianten in „laccase domain-containing 1“ (LACC1) als Ursache einer juvenilen Arthritis. Zeitschrift für Rheumatologie. 83(1). 4–14.
9.
Uruha, Akinori, Jens Klotsche, Nadine Unterwalder, et al.. (2022). SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies. RMD Open. 8(1). e001934–e001934. 25 indexed citations
10.
Chang, Hyun‐Dong, Andreas Radbruch, Tilmann Kallinich, et al.. (2022). Wie T-Lymphozyten rheumatische Entzündung koordinieren. Zeitschrift für Rheumatologie. 81(8). 635–641.
11.
12.
Klotsche, Jens, Thomas Rose, Tilmann Kallinich, et al.. (2021). Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus. Lara D. Veeken. 61(8). 3396–3400. 10 indexed citations
13.
Meisel, Christian, Tim Meyer, Erwin Lankes, et al.. (2021). Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1. Journal of Clinical Investigation. 131(14). 55 indexed citations
14.
Niewerth, Martina, Claudia Sengler, Daniel Windschall, et al.. (2021). POS1321 MENTAL HEALTH SCREENING IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS. Annals of the Rheumatic Diseases. 80. 943–943. 3 indexed citations
15.
Bonnekoh, Hanna, et al.. (2020). Spectrum of Genetic Autoinflammatory Diseases Presenting with Cutaneous Symptoms. Acta Dermato Venereologica. 100(7). adv00091–151. 9 indexed citations
16.
17.
Preuße, Corinna, Yves Allenbach, Olaf Hoffmann, et al.. (2016). Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis. Acta Neuropathologica Communications. 4(1). 45–45. 46 indexed citations
18.
Erer, Burak, Erkan Demirkaya, Seza Özen, & Tilmann Kallinich. (2015). What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review. Rheumatology International. 36(4). 483–487. 33 indexed citations
19.
Beier, Katja C., Andreas Hutloff, Max Löhning, et al.. (2004). Inducible costimulator–positive T cells are required for allergen-induced local B-cell infiltration and antigen-specific IgE production in lung tissue. Journal of Allergy and Clinical Immunology. 114(4). 775–782. 26 indexed citations
20.
Kallinich, Tilmann, J. Marcus Muche, Shixin Qin, et al.. (2003). Chemokine Receptor Expression on Neoplastic and Reactive T Cells in the Skin at Different Stages of Mycosis Fungoides. Journal of Investigative Dermatology. 121(5). 1045–1052. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sinisa Savic Breakdown of academic impact, for papers by Norbert Blank Breakdown of academic impact, for papers by Kieron Leslie Breakdown of academic impact, for papers by Joung‐Liang Lan Breakdown of academic impact, for papers by Alexandre Bélot Breakdown of academic impact, for papers by Francesco Caso Breakdown of academic impact, for papers by Michael Frosch Breakdown of academic impact, for papers by Serena Colafrancesco Breakdown of academic impact, for papers by Akrivi Chrysanthopoulou Breakdown of academic impact, for papers by Toru Mima
Rankless by CCL
2026